中美医药化工产业全球价值链比较研究
Comparative study on global value chain of pharmaceutical and chemical industry between China and America
-
摘要: 以2018年OECD-WTO编制的TiVA(贸易增加值数据库)为依据,对中美医药化工产业的全球价值链进行比较,结果表明:其一,中国的出口产品较多地被进口国用作中间投入品进入到出口产品的生产环节中,作为最终产品被进口国直接吸收的比例较低;其二,从中美医药化工产业的双边贸易来看,中国对美出口产品中对美国中间产品的依赖程度远高于美国对中国出口产品中对中国中间产品的依赖程度;其三,从价值链参与度来看,中美医药化工产业参与全球价值链的活跃程度大体相当,但相对于美国,中国前向参与度较低,后向参与度较高。后疫情时代,在美国“价值链回迁”重要战略选择下,中国应做好充分准备,以应对全球价值链中断的极端不利影响。
-
-
[1]
JOHNSON R C.Five facts about value-added exports and implications for macroeconomics and trade research[J].Journal of Economic Perspectives,2014(2):131.
-
[2]
HUMMELS D,ISHII J,YI K.The nature and growth of vertical specialization in world trade[J].Journal of International Economics, 2001(1):85.
-
[3]
KOOPMAN R,WANG Z,WEI S.How much of Chinese exports is really made in China? Assessing domestic value-added when processing trade is pervasive[R].National Bureau of Economic Research,2008.
-
[4]
FALLY T.Production staging:Measurement and facts[D].Boulder:University of Colorado Boulder,2012.
-
[5]
ANTRAS P,CHOR D,FALLY T,et al.Measuring the upstreamness of production and trade flows[J].American Economic Review,2012(3):421.
-
[6]
KOOPMAN R,POWERS W,WANG Z,et al.Give credit where credit is due:Tracing value added in global production chains[R].National Bureau of Economic Research,2010.
-
[7]
KOOPMAN R,WANG Z,WEI S.Tracing value-added and double counting in gross exports[J].American Economic Review,2014(2):478.
-
[8]
WANG Z,WEI S,ZHU K.Quantifying international production sharing at the bilateral and sector levels[R].National Bureau of Economic Research,2013.
-
[9]
王岚,盛斌.全球价值链分工背景下的中美增加值贸易与双边贸易利益[J].财经研究,2014(9):99.
-
[10]
于津平,邓娟.垂直专业化、出口技术含量与全球价值链分工地位[J].世界经济与政治论坛,2014(2):47.
-
[11]
黄灿,林桂军.全球价值链分工地位的影响因素研究:基于发展中国家的视角[J].对外经济贸易大学学报,2017(2):9.
-
[12]
郑丹青,于津平.中国制造业增加值贸易成本测度与影响研究:基于价值链分工地位视角[J].产业经济研究,2019(2):15.
-
[13]
于柳荫,申成霖.创新驱动下的医药科技企业绿色价值链模型构建[J].财经问题研究,2014(S1):109.
-
[14]
李国平,方晓晖.基于价值链分工的跨国生物医药企业在华布局模式[J].地域研究与开发,2016(4):8.
-
[15]
刘光东,丁洁,武博.基于全球价值链的我国高新技术产业集群升级研究:以生物医药产业集群为例[J].软科学,2011(3):39.
-
[16]
王文涛,付剑峰,朱义.企业创新、价值链扩张与制造业盈利能力:以中国医药制造企业为例[J].中国工业经济,2012(4):58.
-
[17]
JOHNSON R C,NOGUERA G.Accounting for intermediates:Production sharing and trade in value added[J].Journal of International Economics,2012(2):234.
-
[1]
计量
- PDF下载量: 10
- 文章访问数: 1069
- 引证文献数: 0